Filter
4594
Filtered Results: 4594
Text search:
National
Drug
Policy
Featured
Recommendations
379
New Publications
1272
Language
Document type
No document type
2838
Studies & Reports
713
Guidelines
534
Manuals
192
Strategic & Response Plan
168
Training Material
54
Fact sheets
49
Situation Updates
22
Infographics
8
Resource Platforms
7
Brochures
5
Online Courses
3
App
1
Countries / Regions
India
237
Kenya
155
Global
153
Uganda
117
South Africa
113
Western and Central Europe
107
Nigeria
106
Ethiopia
105
Nepal
93
Liberia
81
Tanzania
80
Malawi
79
Sierra Leone
78
Zambia
76
Myanmar / Burma
75
Ghana
73
Bangladesh
65
Latin America and the Carribbean
64
Africa
60
Eastern Europe
58
Namibia
56
Rwanda
54
Ukraine
52
Zimbabwe
43
Asia
42
Philippines
36
Cambodia
35
South–East Asia Region
35
Lesotho
33
Indonesia
32
Russia
29
Botswana
27
Mozambique
21
Eswatini/ Swaziland
21
Congo, Democratic Republic of
20
Syria
19
Colombia
18
Senegal
18
Burkina Faso
17
East and Southern Africa
14
Haiti
13
Germany
12
West and Central Africa
12
Brazil
12
Cameroon
11
Venezuela
11
Middle East and North Africa
11
Eastern Europe and Central Asia
11
South Sudan
11
Pakistan
11
Tajikistan
10
Thailand
10
Albania
10
Guinea
10
Georgia
10
Peru
9
Afghanistan
8
Vietnam
8
Sudan
8
Paraguay
7
North Macedonia
6
Benin
6
China
6
Laos
6
Armenia
6
USA
6
Moldova
6
Sri Lanka
6
Yemen
6
Mexico
5
El Salvador
5
Western Pacific Region
5
North America
5
Timor Leste/ East Timor
4
Iran
4
Jordan
4
United Kingdom
4
Argentina
4
Central African Republic
4
Libya
4
Iraq
4
Somalia
4
Turkey
3
Fiji
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Bolivia
3
Lebanon
3
Palestine
3
Bhutan
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Romania
2
Poland
2
Mali
2
North Korea
1
Switzerland
1
Gambia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Egypt
1
Greece
1
Honduras
1
Angola
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1880
Clinical Guidelines
341
Public Health
219
Women & Child Health
166
Key Resources
135
Pharmacy & Technologies
51
Capacity Building
44
Toolboxes
HIV
590
TB
483
Mental Health
411
AMR
241
COVID-19
159
Pharmacy
135
NTDs
115
NCDs
83
Malaria
79
Caregiver
77
Planetary Health
65
Rapid Response
57
Ebola & Marburg
56
Global Health Education
53
Refugee
52
Disability
52
Conflict
46
Health Financing Toolbox
41
Polio
24
Natural Hazards
14
Specific Hazards
13
Cholera
12
Social Ethics
9
Zika
8
2.0 Rapid Response
6
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
This resource aims to provide relevant and practical guidance to DRR practitioners (policy and programme colleagues), on how to ensure inclusion - particularly of vulnerable groups - in Community-Based DRR (CBDRR) initiatives in Myanmar. It comprises an overall Framework for inclusive CBDRR and a nu...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development.
The plan includes strengthening prevention through lo...
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
The "Integrated Management of Malaria Training – Health Worker’s Manual" is a practical guide developed by Uganda’s Ministry of Health to train healthcare workers at all levels in the effective diagnosis, treatment, prevention, and management of malaria. It aligns with national malaria treatme...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
Adolescent alcohol-related behaviours: trends and inequalities in the WHO European Region, 2002–2014
Observations from the Health Behaviour in School-aged Children (HBSC) WHO collaborative cross-national study
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
A key component of achieving control and elimination of neglected tropical diseases (NTDs) is effective supply chain management of preventive chemotherapy drugs for Mass Drug Administration (MDA) for trachoma, river blindness, lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis....
